Work

Author response for "Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐ O trial"

Year: 2024

Type: peer-review

Source: Publons reviews and discussion

DOI: 10.1111/dom.15957/v2/response1

Authors: Hertzel C. Gerstein, Mu Yang, Shun Fu Lee, Kelley R. H. Branch, Stefano Del Prato, Carolyn S. P. Lam, Renato D. Lopes, Richard Pratley, Julio Rosenstock, Naveed Sattar

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402565399

Cites:

Cited by:

Related to: 10